(Q34494436)

English

Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort (English)

1 reference

Europe PubMed Central

2 August 2017

anti-retroviral agent

0 references

author name string

Mangili A

1

1 reference

Europe PubMed Central

2 August 2017

Murman DH

2

1 reference

Europe PubMed Central

2 August 2017

Zampini AM

3

1 reference

Europe PubMed Central

2 August 2017

Wanke CA

4

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

7 February 2006

1 reference

Europe PubMed Central

2 August 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

2 August 2017

42

1 reference

Europe PubMed Central

2 August 2017

6

1 reference

Europe PubMed Central

2 August 2017

836-842

1 reference

Europe PubMed Central

2 August 2017

Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Pathogenesis and consequences of HIV-associated wasting

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003.

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999.

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Relation of lean body mass to health-related quality of life in persons with HIV.

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Nutrient intake and body weight in a large HIV cohort that includes women and minorities

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Difficulty swallowing and lack of receipt of highly active antiretroviral therapy predict acute weight loss in human immunodeficiency virus disease

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

The effect of protease inhibitors on weight and body composition in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Understanding the role of HIV load in determining weight change in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men.

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Fat distribution is altered in HIV-infected men without clinical evidence of the HIV lipodystrophy syndrome.

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Role of acquired immune deficiency syndrome-defining conditions in human immunodeficiency virus-associated wasting

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss.

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Efficacy of selected treatments of HIV wasting: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Comparing megestrol acetate therapy with oxandrolone therapy for HIV-related weight loss: similar results in 2 months

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

A comparison of the clinical and cost-effectiveness of 3 intervention strategies for AIDS wasting

1 reference

https://api.crossref.org/works/10.1086%2F500398

21 January 2018

Identifiers

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34494436&oldid=1981505071"